Industry stakeholders say HHS’ proposal to combat drug shortages by incentivizing hospitals to change their buying practices is overlooking the role of wholesalers and group purchasing organizations (GPOs) that control 90% of generic drug purchasing for most hospitals. One major hospital group says its members are “customers” in the drug supply chain and manufacturers, distributors, GPOs and FDA have a more “direct” role in ensuring the supply chain’s resilience. The Association for Accessible Medicines (AAM), which lobbies for generic drug...